Use of commercial porous ceramic particles for sustained drug delivery

被引:56
作者
Byrne, RS [1 ]
Deasy, PB [1 ]
机构
[1] Univ Dublin Trinity Coll, Sch Pharm, Dept Pharmaceut & Pharmaceut Technol, Dublin 2, Ireland
关键词
diltiazem HC1; floating; microparticles; porous ceramics; sustained release; vacuum loading;
D O I
10.1016/S0378-5173(02)00357-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Three commercially available microparticulate porous ceramics, N-light N3, Starlight SLK1000 and Carbolite 16/20, were characterised using a range of techniques. Starlight SLK1000 and Carbolite 16/20 were principally composed of mullite, while N-light N3 was principally composed of quartz. Each porous ceramic was partly open-cell with varying porosities and pore size distributions. Using a novel vacuum loading technique, N-light N3 was loaded with benzoic acid, sodium benzoate and diltiazem HCl, while Starlight SLK1000 and Carbolite 16/20 were loaded with diltiazem HCl. The drug loading was influenced by the solution concentration and by the porosity and bulk density of the ceramic. In vitro dissolution testing of the loaded porous microparticles showed an initial burst release of each drug followed by sustained release. The release was influenced by the surface pore size distribution of the ceramic and by electrostatic interactions between the interior and exterior microparticle surfaces and the drug. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:61 / 73
页数:13
相关论文
共 15 条
[1]  
[Anonymous], 1998, POROUS MAT PROCESS T
[2]   DISTRIBUTION OF PELLETS IN GASTROINTESTINAL-TRACT - INFLUENCE ON TRANSIT-TIME EXERTED BY DENSITY OR DIAMETER OF PELLETS [J].
BECHGAARD, H ;
LADEFOGED, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (11) :690-692
[3]   Synthesis of antibiotic-loaded interporous hydroxyapatite blocks by vacuum method and in vitro drug release testing [J].
Itokazu, M ;
Yang, WY ;
Aoki, T ;
Ohara, A ;
Kato, N .
BIOMATERIALS, 1998, 19 (7-9) :817-819
[4]   Local drug delivery system using ceramics: vacuum method for impregnating a chemotherapeutic agent into a porous hydroxyapatite block [J].
Itokazu, M ;
Esaki, M ;
Yamamoto, K ;
Tanemori, T ;
Kasai, T .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 1999, 10 (04) :249-252
[5]   PREPARATION OF MULTIPLE UNIT HOLLOW MICROSPHERES (MICROBALLOONS) WITH ACRYLIC RESIN CONTAINING TRANILAST AND THEIR DRUG RELEASE CHARACTERISTICS (INVITRO) AND FLOATING BEHAVIOR (INVIVO) [J].
KAWASHIMA, Y ;
NIWA, T ;
TAKEUCHI, H ;
HINO, T ;
ITO, Y .
JOURNAL OF CONTROLLED RELEASE, 1991, 16 (03) :279-290
[6]   Porous ceramic bodies for drug delivery [J].
Krajewski, A ;
Ravaglioli, A ;
Roncari, E ;
Pinasco, P ;
Montanari, L .
JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE, 2000, 11 (12) :763-771
[7]   Calcium phosphate ceramics as drug-delivery system for anticancer therapy [J].
Landi, E ;
Orlandi, L ;
Spagna, G ;
Tampieri, A ;
Zaffaroni, N .
BIOCERAMICS, 2000, 192-1 :901-904
[8]   Influence of porous microarchitecture on the in-vitro dissolution and biological behaviour of porous calcium phosphate ceramics [J].
Liu, DM .
POROUS MATERIALS FOR TISSUE ENGINEERING, 1997, 250 :183-208
[9]   Ceramic foams by powder processing [J].
Montanaro, L ;
Jorand, Y ;
Fantozzi, G ;
Negro, A .
JOURNAL OF THE EUROPEAN CERAMIC SOCIETY, 1998, 18 (09) :1339-1350
[10]   PRACTICAL USE OF MERCURY POROSIMETRY IN THE STUDY OF POROUS SOLIDS [J].
MOSCOU, L ;
LUB, S .
POWDER TECHNOLOGY, 1981, 29 (01) :45-52